Global Closed-loop Automated Insulin Delivery (AID) System Market Growth 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
Automated Insulin Delivery (AID) systems automatically adjust insulin delivery to help control blood glucose levels, reduce hypoglycemia, and increase time in range. AID systems are often called hybrid closed loop systems and allow for a complete circle of communication between a continuous glucose monitor (CGM) and insulin Pod/pump.
The global Closed-loop Automated Insulin Delivery (AID) System market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.
LP Information, Inc. (LPI) ' newest research report, the “Closed-loop Automated Insulin Delivery (AID) System Industry Forecast” looks at past sales and reviews total world Closed-loop Automated Insulin Delivery (AID) System sales in 2023, providing a comprehensive analysis by region and market sector of projected Closed-loop Automated Insulin Delivery (AID) System sales for 2024 through 2030. With Closed-loop Automated Insulin Delivery (AID) System sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Closed-loop Automated Insulin Delivery (AID) System industry.
This Insight Report provides a comprehensive analysis of the global Closed-loop Automated Insulin Delivery (AID) System landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Closed-loop Automated Insulin Delivery (AID) System portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Closed-loop Automated Insulin Delivery (AID) System market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Closed-loop Automated Insulin Delivery (AID) System and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Closed-loop Automated Insulin Delivery (AID) System.
United States market for Closed-loop Automated Insulin Delivery (AID) System is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for Closed-loop Automated Insulin Delivery (AID) System is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for Closed-loop Automated Insulin Delivery (AID) System is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key Closed-loop Automated Insulin Delivery (AID) System players cover Medtronic, Tandem Diabetes Care, Admetsys, Insulet, Defymed, etc. In terms of revenue, the global two largest companies occupied for a share nearly
% in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of Closed-loop Automated Insulin Delivery (AID) System market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Closed-loop Automated Insulin Delivery (AID) System market?
What factors are driving Closed-loop Automated Insulin Delivery (AID) System market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Closed-loop Automated Insulin Delivery (AID) System market opportunities vary by end market size?
How does Closed-loop Automated Insulin Delivery (AID) System break out by Type, by Application?
Automated Insulin Delivery (AID) systems automatically adjust insulin delivery to help control blood glucose levels, reduce hypoglycemia, and increase time in range. AID systems are often called hybrid closed loop systems and allow for a complete circle of communication between a continuous glucose monitor (CGM) and insulin Pod/pump.
The global Closed-loop Automated Insulin Delivery (AID) System market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.
LP Information, Inc. (LPI) ' newest research report, the “Closed-loop Automated Insulin Delivery (AID) System Industry Forecast” looks at past sales and reviews total world Closed-loop Automated Insulin Delivery (AID) System sales in 2023, providing a comprehensive analysis by region and market sector of projected Closed-loop Automated Insulin Delivery (AID) System sales for 2024 through 2030. With Closed-loop Automated Insulin Delivery (AID) System sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Closed-loop Automated Insulin Delivery (AID) System industry.
This Insight Report provides a comprehensive analysis of the global Closed-loop Automated Insulin Delivery (AID) System landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Closed-loop Automated Insulin Delivery (AID) System portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Closed-loop Automated Insulin Delivery (AID) System market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Closed-loop Automated Insulin Delivery (AID) System and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Closed-loop Automated Insulin Delivery (AID) System.
United States market for Closed-loop Automated Insulin Delivery (AID) System is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for Closed-loop Automated Insulin Delivery (AID) System is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for Closed-loop Automated Insulin Delivery (AID) System is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key Closed-loop Automated Insulin Delivery (AID) System players cover Medtronic, Tandem Diabetes Care, Admetsys, Insulet, Defymed, etc. In terms of revenue, the global two largest companies occupied for a share nearly
% in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of Closed-loop Automated Insulin Delivery (AID) System market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Hybrid Closed Loop Systems
- DIY Closed Loop Systems
- Children with Type 1 Diabetes
- Adults with Type 1 Diabetes
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Medtronic
- Tandem Diabetes Care
- Admetsys
- Insulet
- Defymed
- Beta Bionics (iLet)
- Bigfoot Biomedical
- Dexcom
- MicroTech Medical (Hangzhou) Co., Ltd.
- Medtrum
What is the 10-year outlook for the global Closed-loop Automated Insulin Delivery (AID) System market?
What factors are driving Closed-loop Automated Insulin Delivery (AID) System market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Closed-loop Automated Insulin Delivery (AID) System market opportunities vary by end market size?
How does Closed-loop Automated Insulin Delivery (AID) System break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Closed-loop Automated Insulin Delivery (AID) System Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Closed-loop Automated Insulin Delivery (AID) System by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Closed-loop Automated Insulin Delivery (AID) System by Country/Region, 2019, 2023 & 2030
2.2 Closed-loop Automated Insulin Delivery (AID) System Segment by Type
2.2.1 Hybrid Closed Loop Systems
2.2.2 DIY Closed Loop Systems
2.3 Closed-loop Automated Insulin Delivery (AID) System Sales by Type
2.3.1 Global Closed-loop Automated Insulin Delivery (AID) System Sales Market Share by Type (2019-2024)
2.3.2 Global Closed-loop Automated Insulin Delivery (AID) System Revenue and Market Share by Type (2019-2024)
2.3.3 Global Closed-loop Automated Insulin Delivery (AID) System Sale Price by Type (2019-2024)
2.4 Closed-loop Automated Insulin Delivery (AID) System Segment by Application
2.4.1 Children with Type 1 Diabetes
2.4.2 Adults with Type 1 Diabetes
2.5 Closed-loop Automated Insulin Delivery (AID) System Sales by Application
2.5.1 Global Closed-loop Automated Insulin Delivery (AID) System Sale Market Share by Application (2019-2024)
2.5.2 Global Closed-loop Automated Insulin Delivery (AID) System Revenue and Market Share by Application (2019-2024)
2.5.3 Global Closed-loop Automated Insulin Delivery (AID) System Sale Price by Application (2019-2024)
3 GLOBAL BY COMPANY
3.1 Global Closed-loop Automated Insulin Delivery (AID) System Breakdown Data by Company
3.1.1 Global Closed-loop Automated Insulin Delivery (AID) System Annual Sales by Company (2019-2024)
3.1.2 Global Closed-loop Automated Insulin Delivery (AID) System Sales Market Share by Company (2019-2024)
3.2 Global Closed-loop Automated Insulin Delivery (AID) System Annual Revenue by Company (2019-2024)
3.2.1 Global Closed-loop Automated Insulin Delivery (AID) System Revenue by Company (2019-2024)
3.2.2 Global Closed-loop Automated Insulin Delivery (AID) System Revenue Market Share by Company (2019-2024)
3.3 Global Closed-loop Automated Insulin Delivery (AID) System Sale Price by Company
3.4 Key Manufacturers Closed-loop Automated Insulin Delivery (AID) System Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Closed-loop Automated Insulin Delivery (AID) System Product Location Distribution
3.4.2 Players Closed-loop Automated Insulin Delivery (AID) System Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR CLOSED-LOOP AUTOMATED INSULIN DELIVERY (AID) SYSTEM BY GEOGRAPHIC REGION
4.1 World Historic Closed-loop Automated Insulin Delivery (AID) System Market Size by Geographic Region (2019-2024)
4.1.1 Global Closed-loop Automated Insulin Delivery (AID) System Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Closed-loop Automated Insulin Delivery (AID) System Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Closed-loop Automated Insulin Delivery (AID) System Market Size by Country/Region (2019-2024)
4.2.1 Global Closed-loop Automated Insulin Delivery (AID) System Annual Sales by Country/Region (2019-2024)
4.2.2 Global Closed-loop Automated Insulin Delivery (AID) System Annual Revenue by Country/Region (2019-2024)
4.3 Americas Closed-loop Automated Insulin Delivery (AID) System Sales Growth
4.4 APAC Closed-loop Automated Insulin Delivery (AID) System Sales Growth
4.5 Europe Closed-loop Automated Insulin Delivery (AID) System Sales Growth
4.6 Middle East & Africa Closed-loop Automated Insulin Delivery (AID) System Sales Growth
5 AMERICAS
5.1 Americas Closed-loop Automated Insulin Delivery (AID) System Sales by Country
5.1.1 Americas Closed-loop Automated Insulin Delivery (AID) System Sales by Country (2019-2024)
5.1.2 Americas Closed-loop Automated Insulin Delivery (AID) System Revenue by Country (2019-2024)
5.2 Americas Closed-loop Automated Insulin Delivery (AID) System Sales by Type (2019-2024)
5.3 Americas Closed-loop Automated Insulin Delivery (AID) System Sales by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Closed-loop Automated Insulin Delivery (AID) System Sales by Region
6.1.1 APAC Closed-loop Automated Insulin Delivery (AID) System Sales by Region (2019-2024)
6.1.2 APAC Closed-loop Automated Insulin Delivery (AID) System Revenue by Region (2019-2024)
6.2 APAC Closed-loop Automated Insulin Delivery (AID) System Sales by Type (2019-2024)
6.3 APAC Closed-loop Automated Insulin Delivery (AID) System Sales by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Closed-loop Automated Insulin Delivery (AID) System by Country
7.1.1 Europe Closed-loop Automated Insulin Delivery (AID) System Sales by Country (2019-2024)
7.1.2 Europe Closed-loop Automated Insulin Delivery (AID) System Revenue by Country (2019-2024)
7.2 Europe Closed-loop Automated Insulin Delivery (AID) System Sales by Type (2019-2024)
7.3 Europe Closed-loop Automated Insulin Delivery (AID) System Sales by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Closed-loop Automated Insulin Delivery (AID) System by Country
8.1.1 Middle East & Africa Closed-loop Automated Insulin Delivery (AID) System Sales by Country (2019-2024)
8.1.2 Middle East & Africa Closed-loop Automated Insulin Delivery (AID) System Revenue by Country (2019-2024)
8.2 Middle East & Africa Closed-loop Automated Insulin Delivery (AID) System Sales by Type (2019-2024)
8.3 Middle East & Africa Closed-loop Automated Insulin Delivery (AID) System Sales by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Closed-loop Automated Insulin Delivery (AID) System
10.3 Manufacturing Process Analysis of Closed-loop Automated Insulin Delivery (AID) System
10.4 Industry Chain Structure of Closed-loop Automated Insulin Delivery (AID) System
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Closed-loop Automated Insulin Delivery (AID) System Distributors
11.3 Closed-loop Automated Insulin Delivery (AID) System Customer
12 WORLD FORECAST REVIEW FOR CLOSED-LOOP AUTOMATED INSULIN DELIVERY (AID) SYSTEM BY GEOGRAPHIC REGION
12.1 Global Closed-loop Automated Insulin Delivery (AID) System Market Size Forecast by Region
12.1.1 Global Closed-loop Automated Insulin Delivery (AID) System Forecast by Region (2025-2030)
12.1.2 Global Closed-loop Automated Insulin Delivery (AID) System Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country (2025-2030)
12.3 APAC Forecast by Region (2025-2030)
12.4 Europe Forecast by Country (2025-2030)
12.5 Middle East & Africa Forecast by Country (2025-2030)
12.6 Global Closed-loop Automated Insulin Delivery (AID) System Forecast by Type (2025-2030)
12.7 Global Closed-loop Automated Insulin Delivery (AID) System Forecast by Application (2025-2030)
13 KEY PLAYERS ANALYSIS
13.1 Medtronic
13.1.1 Medtronic Company Information
13.1.2 Medtronic Closed-loop Automated Insulin Delivery (AID) System Product Portfolios and Specifications
13.1.3 Medtronic Closed-loop Automated Insulin Delivery (AID) System Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Medtronic Main Business Overview
13.1.5 Medtronic Latest Developments
13.2 Tandem Diabetes Care
13.2.1 Tandem Diabetes Care Company Information
13.2.2 Tandem Diabetes Care Closed-loop Automated Insulin Delivery (AID) System Product Portfolios and Specifications
13.2.3 Tandem Diabetes Care Closed-loop Automated Insulin Delivery (AID) System Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Tandem Diabetes Care Main Business Overview
13.2.5 Tandem Diabetes Care Latest Developments
13.3 Admetsys
13.3.1 Admetsys Company Information
13.3.2 Admetsys Closed-loop Automated Insulin Delivery (AID) System Product Portfolios and Specifications
13.3.3 Admetsys Closed-loop Automated Insulin Delivery (AID) System Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Admetsys Main Business Overview
13.3.5 Admetsys Latest Developments
13.4 Insulet
13.4.1 Insulet Company Information
13.4.2 Insulet Closed-loop Automated Insulin Delivery (AID) System Product Portfolios and Specifications
13.4.3 Insulet Closed-loop Automated Insulin Delivery (AID) System Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Insulet Main Business Overview
13.4.5 Insulet Latest Developments
13.5 Defymed
13.5.1 Defymed Company Information
13.5.2 Defymed Closed-loop Automated Insulin Delivery (AID) System Product Portfolios and Specifications
13.5.3 Defymed Closed-loop Automated Insulin Delivery (AID) System Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Defymed Main Business Overview
13.5.5 Defymed Latest Developments
13.6 Beta Bionics (iLet)
13.6.1 Beta Bionics (iLet) Company Information
13.6.2 Beta Bionics (iLet) Closed-loop Automated Insulin Delivery (AID) System Product Portfolios and Specifications
13.6.3 Beta Bionics (iLet) Closed-loop Automated Insulin Delivery (AID) System Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 Beta Bionics (iLet) Main Business Overview
13.6.5 Beta Bionics (iLet) Latest Developments
13.7 Bigfoot Biomedical
13.7.1 Bigfoot Biomedical Company Information
13.7.2 Bigfoot Biomedical Closed-loop Automated Insulin Delivery (AID) System Product Portfolios and Specifications
13.7.3 Bigfoot Biomedical Closed-loop Automated Insulin Delivery (AID) System Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 Bigfoot Biomedical Main Business Overview
13.7.5 Bigfoot Biomedical Latest Developments
13.8 Dexcom
13.8.1 Dexcom Company Information
13.8.2 Dexcom Closed-loop Automated Insulin Delivery (AID) System Product Portfolios and Specifications
13.8.3 Dexcom Closed-loop Automated Insulin Delivery (AID) System Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 Dexcom Main Business Overview
13.8.5 Dexcom Latest Developments
13.9 MicroTech Medical (Hangzhou) Co., Ltd.
13.9.1 MicroTech Medical (Hangzhou) Co., Ltd. Company Information
13.9.2 MicroTech Medical (Hangzhou) Co., Ltd. Closed-loop Automated Insulin Delivery (AID) System Product Portfolios and Specifications
13.9.3 MicroTech Medical (Hangzhou) Co., Ltd. Closed-loop Automated Insulin Delivery (AID) System Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 MicroTech Medical (Hangzhou) Co., Ltd. Main Business Overview
13.9.5 MicroTech Medical (Hangzhou) Co., Ltd. Latest Developments
13.10 Medtrum
13.10.1 Medtrum Company Information
13.10.2 Medtrum Closed-loop Automated Insulin Delivery (AID) System Product Portfolios and Specifications
13.10.3 Medtrum Closed-loop Automated Insulin Delivery (AID) System Sales, Revenue, Price and Gross Margin (2019-2024)
13.10.4 Medtrum Main Business Overview
13.10.5 Medtrum Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Closed-loop Automated Insulin Delivery (AID) System Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Closed-loop Automated Insulin Delivery (AID) System by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Closed-loop Automated Insulin Delivery (AID) System by Country/Region, 2019, 2023 & 2030
2.2 Closed-loop Automated Insulin Delivery (AID) System Segment by Type
2.2.1 Hybrid Closed Loop Systems
2.2.2 DIY Closed Loop Systems
2.3 Closed-loop Automated Insulin Delivery (AID) System Sales by Type
2.3.1 Global Closed-loop Automated Insulin Delivery (AID) System Sales Market Share by Type (2019-2024)
2.3.2 Global Closed-loop Automated Insulin Delivery (AID) System Revenue and Market Share by Type (2019-2024)
2.3.3 Global Closed-loop Automated Insulin Delivery (AID) System Sale Price by Type (2019-2024)
2.4 Closed-loop Automated Insulin Delivery (AID) System Segment by Application
2.4.1 Children with Type 1 Diabetes
2.4.2 Adults with Type 1 Diabetes
2.5 Closed-loop Automated Insulin Delivery (AID) System Sales by Application
2.5.1 Global Closed-loop Automated Insulin Delivery (AID) System Sale Market Share by Application (2019-2024)
2.5.2 Global Closed-loop Automated Insulin Delivery (AID) System Revenue and Market Share by Application (2019-2024)
2.5.3 Global Closed-loop Automated Insulin Delivery (AID) System Sale Price by Application (2019-2024)
3 GLOBAL BY COMPANY
3.1 Global Closed-loop Automated Insulin Delivery (AID) System Breakdown Data by Company
3.1.1 Global Closed-loop Automated Insulin Delivery (AID) System Annual Sales by Company (2019-2024)
3.1.2 Global Closed-loop Automated Insulin Delivery (AID) System Sales Market Share by Company (2019-2024)
3.2 Global Closed-loop Automated Insulin Delivery (AID) System Annual Revenue by Company (2019-2024)
3.2.1 Global Closed-loop Automated Insulin Delivery (AID) System Revenue by Company (2019-2024)
3.2.2 Global Closed-loop Automated Insulin Delivery (AID) System Revenue Market Share by Company (2019-2024)
3.3 Global Closed-loop Automated Insulin Delivery (AID) System Sale Price by Company
3.4 Key Manufacturers Closed-loop Automated Insulin Delivery (AID) System Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Closed-loop Automated Insulin Delivery (AID) System Product Location Distribution
3.4.2 Players Closed-loop Automated Insulin Delivery (AID) System Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR CLOSED-LOOP AUTOMATED INSULIN DELIVERY (AID) SYSTEM BY GEOGRAPHIC REGION
4.1 World Historic Closed-loop Automated Insulin Delivery (AID) System Market Size by Geographic Region (2019-2024)
4.1.1 Global Closed-loop Automated Insulin Delivery (AID) System Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Closed-loop Automated Insulin Delivery (AID) System Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Closed-loop Automated Insulin Delivery (AID) System Market Size by Country/Region (2019-2024)
4.2.1 Global Closed-loop Automated Insulin Delivery (AID) System Annual Sales by Country/Region (2019-2024)
4.2.2 Global Closed-loop Automated Insulin Delivery (AID) System Annual Revenue by Country/Region (2019-2024)
4.3 Americas Closed-loop Automated Insulin Delivery (AID) System Sales Growth
4.4 APAC Closed-loop Automated Insulin Delivery (AID) System Sales Growth
4.5 Europe Closed-loop Automated Insulin Delivery (AID) System Sales Growth
4.6 Middle East & Africa Closed-loop Automated Insulin Delivery (AID) System Sales Growth
5 AMERICAS
5.1 Americas Closed-loop Automated Insulin Delivery (AID) System Sales by Country
5.1.1 Americas Closed-loop Automated Insulin Delivery (AID) System Sales by Country (2019-2024)
5.1.2 Americas Closed-loop Automated Insulin Delivery (AID) System Revenue by Country (2019-2024)
5.2 Americas Closed-loop Automated Insulin Delivery (AID) System Sales by Type (2019-2024)
5.3 Americas Closed-loop Automated Insulin Delivery (AID) System Sales by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Closed-loop Automated Insulin Delivery (AID) System Sales by Region
6.1.1 APAC Closed-loop Automated Insulin Delivery (AID) System Sales by Region (2019-2024)
6.1.2 APAC Closed-loop Automated Insulin Delivery (AID) System Revenue by Region (2019-2024)
6.2 APAC Closed-loop Automated Insulin Delivery (AID) System Sales by Type (2019-2024)
6.3 APAC Closed-loop Automated Insulin Delivery (AID) System Sales by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Closed-loop Automated Insulin Delivery (AID) System by Country
7.1.1 Europe Closed-loop Automated Insulin Delivery (AID) System Sales by Country (2019-2024)
7.1.2 Europe Closed-loop Automated Insulin Delivery (AID) System Revenue by Country (2019-2024)
7.2 Europe Closed-loop Automated Insulin Delivery (AID) System Sales by Type (2019-2024)
7.3 Europe Closed-loop Automated Insulin Delivery (AID) System Sales by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Closed-loop Automated Insulin Delivery (AID) System by Country
8.1.1 Middle East & Africa Closed-loop Automated Insulin Delivery (AID) System Sales by Country (2019-2024)
8.1.2 Middle East & Africa Closed-loop Automated Insulin Delivery (AID) System Revenue by Country (2019-2024)
8.2 Middle East & Africa Closed-loop Automated Insulin Delivery (AID) System Sales by Type (2019-2024)
8.3 Middle East & Africa Closed-loop Automated Insulin Delivery (AID) System Sales by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Closed-loop Automated Insulin Delivery (AID) System
10.3 Manufacturing Process Analysis of Closed-loop Automated Insulin Delivery (AID) System
10.4 Industry Chain Structure of Closed-loop Automated Insulin Delivery (AID) System
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Closed-loop Automated Insulin Delivery (AID) System Distributors
11.3 Closed-loop Automated Insulin Delivery (AID) System Customer
12 WORLD FORECAST REVIEW FOR CLOSED-LOOP AUTOMATED INSULIN DELIVERY (AID) SYSTEM BY GEOGRAPHIC REGION
12.1 Global Closed-loop Automated Insulin Delivery (AID) System Market Size Forecast by Region
12.1.1 Global Closed-loop Automated Insulin Delivery (AID) System Forecast by Region (2025-2030)
12.1.2 Global Closed-loop Automated Insulin Delivery (AID) System Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country (2025-2030)
12.3 APAC Forecast by Region (2025-2030)
12.4 Europe Forecast by Country (2025-2030)
12.5 Middle East & Africa Forecast by Country (2025-2030)
12.6 Global Closed-loop Automated Insulin Delivery (AID) System Forecast by Type (2025-2030)
12.7 Global Closed-loop Automated Insulin Delivery (AID) System Forecast by Application (2025-2030)
13 KEY PLAYERS ANALYSIS
13.1 Medtronic
13.1.1 Medtronic Company Information
13.1.2 Medtronic Closed-loop Automated Insulin Delivery (AID) System Product Portfolios and Specifications
13.1.3 Medtronic Closed-loop Automated Insulin Delivery (AID) System Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Medtronic Main Business Overview
13.1.5 Medtronic Latest Developments
13.2 Tandem Diabetes Care
13.2.1 Tandem Diabetes Care Company Information
13.2.2 Tandem Diabetes Care Closed-loop Automated Insulin Delivery (AID) System Product Portfolios and Specifications
13.2.3 Tandem Diabetes Care Closed-loop Automated Insulin Delivery (AID) System Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Tandem Diabetes Care Main Business Overview
13.2.5 Tandem Diabetes Care Latest Developments
13.3 Admetsys
13.3.1 Admetsys Company Information
13.3.2 Admetsys Closed-loop Automated Insulin Delivery (AID) System Product Portfolios and Specifications
13.3.3 Admetsys Closed-loop Automated Insulin Delivery (AID) System Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Admetsys Main Business Overview
13.3.5 Admetsys Latest Developments
13.4 Insulet
13.4.1 Insulet Company Information
13.4.2 Insulet Closed-loop Automated Insulin Delivery (AID) System Product Portfolios and Specifications
13.4.3 Insulet Closed-loop Automated Insulin Delivery (AID) System Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Insulet Main Business Overview
13.4.5 Insulet Latest Developments
13.5 Defymed
13.5.1 Defymed Company Information
13.5.2 Defymed Closed-loop Automated Insulin Delivery (AID) System Product Portfolios and Specifications
13.5.3 Defymed Closed-loop Automated Insulin Delivery (AID) System Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Defymed Main Business Overview
13.5.5 Defymed Latest Developments
13.6 Beta Bionics (iLet)
13.6.1 Beta Bionics (iLet) Company Information
13.6.2 Beta Bionics (iLet) Closed-loop Automated Insulin Delivery (AID) System Product Portfolios and Specifications
13.6.3 Beta Bionics (iLet) Closed-loop Automated Insulin Delivery (AID) System Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 Beta Bionics (iLet) Main Business Overview
13.6.5 Beta Bionics (iLet) Latest Developments
13.7 Bigfoot Biomedical
13.7.1 Bigfoot Biomedical Company Information
13.7.2 Bigfoot Biomedical Closed-loop Automated Insulin Delivery (AID) System Product Portfolios and Specifications
13.7.3 Bigfoot Biomedical Closed-loop Automated Insulin Delivery (AID) System Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 Bigfoot Biomedical Main Business Overview
13.7.5 Bigfoot Biomedical Latest Developments
13.8 Dexcom
13.8.1 Dexcom Company Information
13.8.2 Dexcom Closed-loop Automated Insulin Delivery (AID) System Product Portfolios and Specifications
13.8.3 Dexcom Closed-loop Automated Insulin Delivery (AID) System Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 Dexcom Main Business Overview
13.8.5 Dexcom Latest Developments
13.9 MicroTech Medical (Hangzhou) Co., Ltd.
13.9.1 MicroTech Medical (Hangzhou) Co., Ltd. Company Information
13.9.2 MicroTech Medical (Hangzhou) Co., Ltd. Closed-loop Automated Insulin Delivery (AID) System Product Portfolios and Specifications
13.9.3 MicroTech Medical (Hangzhou) Co., Ltd. Closed-loop Automated Insulin Delivery (AID) System Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 MicroTech Medical (Hangzhou) Co., Ltd. Main Business Overview
13.9.5 MicroTech Medical (Hangzhou) Co., Ltd. Latest Developments
13.10 Medtrum
13.10.1 Medtrum Company Information
13.10.2 Medtrum Closed-loop Automated Insulin Delivery (AID) System Product Portfolios and Specifications
13.10.3 Medtrum Closed-loop Automated Insulin Delivery (AID) System Sales, Revenue, Price and Gross Margin (2019-2024)
13.10.4 Medtrum Main Business Overview
13.10.5 Medtrum Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Closed-loop Automated Insulin Delivery (AID) System Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Closed-loop Automated Insulin Delivery (AID) System Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Hybrid Closed Loop Systems
Table 4. Major Players of DIY Closed Loop Systems
Table 5. Global Closed-loop Automated Insulin Delivery (AID) System Sales by Type (2019-2024) & (K Units)
Table 6. Global Closed-loop Automated Insulin Delivery (AID) System Sales Market Share by Type (2019-2024)
Table 7. Global Closed-loop Automated Insulin Delivery (AID) System Revenue by Type (2019-2024) & ($ million)
Table 8. Global Closed-loop Automated Insulin Delivery (AID) System Revenue Market Share by Type (2019-2024)
Table 9. Global Closed-loop Automated Insulin Delivery (AID) System Sale Price by Type (2019-2024) & (US$/Unit)
Table 10. Global Closed-loop Automated Insulin Delivery (AID) System Sale by Application (2019-2024) & (K Units)
Table 11. Global Closed-loop Automated Insulin Delivery (AID) System Sale Market Share by Application (2019-2024)
Table 12. Global Closed-loop Automated Insulin Delivery (AID) System Revenue by Application (2019-2024) & ($ million)
Table 13. Global Closed-loop Automated Insulin Delivery (AID) System Revenue Market Share by Application (2019-2024)
Table 14. Global Closed-loop Automated Insulin Delivery (AID) System Sale Price by Application (2019-2024) & (US$/Unit)
Table 15. Global Closed-loop Automated Insulin Delivery (AID) System Sales by Company (2019-2024) & (K Units)
Table 16. Global Closed-loop Automated Insulin Delivery (AID) System Sales Market Share by Company (2019-2024)
Table 17. Global Closed-loop Automated Insulin Delivery (AID) System Revenue by Company (2019-2024) & ($ millions)
Table 18. Global Closed-loop Automated Insulin Delivery (AID) System Revenue Market Share by Company (2019-2024)
Table 19. Global Closed-loop Automated Insulin Delivery (AID) System Sale Price by Company (2019-2024) & (US$/Unit)
Table 20. Key Manufacturers Closed-loop Automated Insulin Delivery (AID) System Producing Area Distribution and Sales Area
Table 21. Players Closed-loop Automated Insulin Delivery (AID) System Products Offered
Table 22. Closed-loop Automated Insulin Delivery (AID) System Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Closed-loop Automated Insulin Delivery (AID) System Sales by Geographic Region (2019-2024) & (K Units)
Table 26. Global Closed-loop Automated Insulin Delivery (AID) System Sales Market Share Geographic Region (2019-2024)
Table 27. Global Closed-loop Automated Insulin Delivery (AID) System Revenue by Geographic Region (2019-2024) & ($ millions)
Table 28. Global Closed-loop Automated Insulin Delivery (AID) System Revenue Market Share by Geographic Region (2019-2024)
Table 29. Global Closed-loop Automated Insulin Delivery (AID) System Sales by Country/Region (2019-2024) & (K Units)
Table 30. Global Closed-loop Automated Insulin Delivery (AID) System Sales Market Share by Country/Region (2019-2024)
Table 31. Global Closed-loop Automated Insulin Delivery (AID) System Revenue by Country/Region (2019-2024) & ($ millions)
Table 32. Global Closed-loop Automated Insulin Delivery (AID) System Revenue Market Share by Country/Region (2019-2024)
Table 33. Americas Closed-loop Automated Insulin Delivery (AID) System Sales by Country (2019-2024) & (K Units)
Table 34. Americas Closed-loop Automated Insulin Delivery (AID) System Sales Market Share by Country (2019-2024)
Table 35. Americas Closed-loop Automated Insulin Delivery (AID) System Revenue by Country (2019-2024) & ($ millions)
Table 36. Americas Closed-loop Automated Insulin Delivery (AID) System Sales by Type (2019-2024) & (K Units)
Table 37. Americas Closed-loop Automated Insulin Delivery (AID) System Sales by Application (2019-2024) & (K Units)
Table 38. APAC Closed-loop Automated Insulin Delivery (AID) System Sales by Region (2019-2024) & (K Units)
Table 39. APAC Closed-loop Automated Insulin Delivery (AID) System Sales Market Share by Region (2019-2024)
Table 40. APAC Closed-loop Automated Insulin Delivery (AID) System Revenue by Region (2019-2024) & ($ millions)
Table 41. APAC Closed-loop Automated Insulin Delivery (AID) System Sales by Type (2019-2024) & (K Units)
Table 42. APAC Closed-loop Automated Insulin Delivery (AID) System Sales by Application (2019-2024) & (K Units)
Table 43. Europe Closed-loop Automated Insulin Delivery (AID) System Sales by Country (2019-2024) & (K Units)
Table 44. Europe Closed-loop Automated Insulin Delivery (AID) System Revenue by Country (2019-2024) & ($ millions)
Table 45. Europe Closed-loop Automated Insulin Delivery (AID) System Sales by Type (2019-2024) & (K Units)
Table 46. Europe Closed-loop Automated Insulin Delivery (AID) System Sales by Application (2019-2024) & (K Units)
Table 47. Middle East & Africa Closed-loop Automated Insulin Delivery (AID) System Sales by Country (2019-2024) & (K Units)
Table 48. Middle East & Africa Closed-loop Automated Insulin Delivery (AID) System Revenue Market Share by Country (2019-2024)
Table 49. Middle East & Africa Closed-loop Automated Insulin Delivery (AID) System Sales by Type (2019-2024) & (K Units)
Table 50. Middle East & Africa Closed-loop Automated Insulin Delivery (AID) System Sales by Application (2019-2024) & (K Units)
Table 51. Key Market Drivers & Growth Opportunities of Closed-loop Automated Insulin Delivery (AID) System
Table 52. Key Market Challenges & Risks of Closed-loop Automated Insulin Delivery (AID) System
Table 53. Key Industry Trends of Closed-loop Automated Insulin Delivery (AID) System
Table 54. Closed-loop Automated Insulin Delivery (AID) System Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Closed-loop Automated Insulin Delivery (AID) System Distributors List
Table 57. Closed-loop Automated Insulin Delivery (AID) System Customer List
Table 58. Global Closed-loop Automated Insulin Delivery (AID) System Sales Forecast by Region (2025-2030) & (K Units)
Table 59. Global Closed-loop Automated Insulin Delivery (AID) System Revenue Forecast by Region (2025-2030) & ($ millions)
Table 60. Americas Closed-loop Automated Insulin Delivery (AID) System Sales Forecast by Country (2025-2030) & (K Units)
Table 61. Americas Closed-loop Automated Insulin Delivery (AID) System Annual Revenue Forecast by Country (2025-2030) & ($ millions)
Table 62. APAC Closed-loop Automated Insulin Delivery (AID) System Sales Forecast by Region (2025-2030) & (K Units)
Table 63. APAC Closed-loop Automated Insulin Delivery (AID) System Annual Revenue Forecast by Region (2025-2030) & ($ millions)
Table 64. Europe Closed-loop Automated Insulin Delivery (AID) System Sales Forecast by Country (2025-2030) & (K Units)
Table 65. Europe Closed-loop Automated Insulin Delivery (AID) System Revenue Forecast by Country (2025-2030) & ($ millions)
Table 66. Middle East & Africa Closed-loop Automated Insulin Delivery (AID) System Sales Forecast by Country (2025-2030) & (K Units)
Table 67. Middle East & Africa Closed-loop Automated Insulin Delivery (AID) System Revenue Forecast by Country (2025-2030) & ($ millions)
Table 68. Global Closed-loop Automated Insulin Delivery (AID) System Sales Forecast by Type (2025-2030) & (K Units)
Table 69. Global Closed-loop Automated Insulin Delivery (AID) System Revenue Forecast by Type (2025-2030) & ($ millions)
Table 70. Global Closed-loop Automated Insulin Delivery (AID) System Sales Forecast by Application (2025-2030) & (K Units)
Table 71. Global Closed-loop Automated Insulin Delivery (AID) System Revenue Forecast by Application (2025-2030) & ($ millions)
Table 72. Medtronic Basic Information, Closed-loop Automated Insulin Delivery (AID) System Manufacturing Base, Sales Area and Its Competitors
Table 73. Medtronic Closed-loop Automated Insulin Delivery (AID) System Product Portfolios and Specifications
Table 74. Medtronic Closed-loop Automated Insulin Delivery (AID) System Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 75. Medtronic Main Business
Table 76. Medtronic Latest Developments
Table 77. Tandem Diabetes Care Basic Information, Closed-loop Automated Insulin Delivery (AID) System Manufacturing Base, Sales Area and Its Competitors
Table 78. Tandem Diabetes Care Closed-loop Automated Insulin Delivery (AID) System Product Portfolios and Specifications
Table 79. Tandem Diabetes Care Closed-loop Automated Insulin Delivery (AID) System Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 80. Tandem Diabetes Care Main Business
Table 81. Tandem Diabetes Care Latest Developments
Table 82. Admetsys Basic Information, Closed-loop Automated Insulin Delivery (AID) System Manufacturing Base, Sales Area and Its Competitors
Table 83. Admetsys Closed-loop Automated Insulin Delivery (AID) System Product Portfolios and Specifications
Table 84. Admetsys Closed-loop Automated Insulin Delivery (AID) System Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 85. Admetsys Main Business
Table 86. Admetsys Latest Developments
Table 87. Insulet Basic Information, Closed-loop Automated Insulin Delivery (AID) System Manufacturing Base, Sales Area and Its Competitors
Table 88. Insulet Closed-loop Automated Insulin Delivery (AID) System Product Portfolios and Specifications
Table 89. Insulet Closed-loop Automated Insulin Delivery (AID) System Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 90. Insulet Main Business
Table 91. Insulet Latest Developments
Table 92. Defymed Basic Information, Closed-loop Automated Insulin Delivery (AID) System Manufacturing Base, Sales Area and Its Competitors
Table 93. Defymed Closed-loop Automated Insulin Delivery (AID) System Product Portfolios and Specifications
Table 94. Defymed Closed-loop Automated Insulin Delivery (AID) System Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 95. Defymed Main Business
Table 96. Defymed Latest Developments
Table 97. Beta Bionics (iLet) Basic Information, Closed-loop Automated Insulin Delivery (AID) System Manufacturing Base, Sales Area and Its Competitors
Table 98. Beta Bionics (iLet) Closed-loop Automated Insulin Delivery (AID) System Product Portfolios and Specifications
Table 99. Beta Bionics (iLet) Closed-loop Automated Insulin Delivery (AID) System Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 100. Beta Bionics (iLet) Main Business
Table 101. Beta Bionics (iLet) Latest Developments
Table 102. Bigfoot Biomedical Basic Information, Closed-loop Automated Insulin Delivery (AID) System Manufacturing Base, Sales Area and Its Competitors
Table 103. Bigfoot Biomedical Closed-loop Automated Insulin Delivery (AID) System Product Portfolios and Specifications
Table 104. Bigfoot Biomedical Closed-loop Automated Insulin Delivery (AID) System Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 105. Bigfoot Biomedical Main Business
Table 106. Bigfoot Biomedical Latest Developments
Table 107. Dexcom Basic Information, Closed-loop Automated Insulin Delivery (AID) System Manufacturing Base, Sales Area and Its Competitors
Table 108. Dexcom Closed-loop Automated Insulin Delivery (AID) System Product Portfolios and Specifications
Table 109. Dexcom Closed-loop Automated Insulin Delivery (AID) System Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 110. Dexcom Main Business
Table 111. Dexcom Latest Developments
Table 112. MicroTech Medical (Hangzhou) Co., Ltd. Basic Information, Closed-loop Automated Insulin Delivery (AID) System Manufacturing Base, Sales Area and Its Competitors
Table 113. MicroTech Medical (Hangzhou) Co., Ltd. Closed-loop Automated Insulin Delivery (AID) System Product Portfolios and Specifications
Table 114. MicroTech Medical (Hangzhou) Co., Ltd. Closed-loop Automated Insulin Delivery (AID) System Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 115. MicroTech Medical (Hangzhou) Co., Ltd. Main Business
Table 116. MicroTech Medical (Hangzhou) Co., Ltd. Latest Developments
Table 117. Medtrum Basic Information, Closed-loop Automated Insulin Delivery (AID) System Manufacturing Base, Sales Area and Its Competitors
Table 118. Medtrum Closed-loop Automated Insulin Delivery (AID) System Product Portfolios and Specifications
Table 119. Medtrum Closed-loop Automated Insulin Delivery (AID) System Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 120. Medtrum Main Business
Table 121. Medtrum Latest Developments
Table 1. Closed-loop Automated Insulin Delivery (AID) System Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Closed-loop Automated Insulin Delivery (AID) System Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Hybrid Closed Loop Systems
Table 4. Major Players of DIY Closed Loop Systems
Table 5. Global Closed-loop Automated Insulin Delivery (AID) System Sales by Type (2019-2024) & (K Units)
Table 6. Global Closed-loop Automated Insulin Delivery (AID) System Sales Market Share by Type (2019-2024)
Table 7. Global Closed-loop Automated Insulin Delivery (AID) System Revenue by Type (2019-2024) & ($ million)
Table 8. Global Closed-loop Automated Insulin Delivery (AID) System Revenue Market Share by Type (2019-2024)
Table 9. Global Closed-loop Automated Insulin Delivery (AID) System Sale Price by Type (2019-2024) & (US$/Unit)
Table 10. Global Closed-loop Automated Insulin Delivery (AID) System Sale by Application (2019-2024) & (K Units)
Table 11. Global Closed-loop Automated Insulin Delivery (AID) System Sale Market Share by Application (2019-2024)
Table 12. Global Closed-loop Automated Insulin Delivery (AID) System Revenue by Application (2019-2024) & ($ million)
Table 13. Global Closed-loop Automated Insulin Delivery (AID) System Revenue Market Share by Application (2019-2024)
Table 14. Global Closed-loop Automated Insulin Delivery (AID) System Sale Price by Application (2019-2024) & (US$/Unit)
Table 15. Global Closed-loop Automated Insulin Delivery (AID) System Sales by Company (2019-2024) & (K Units)
Table 16. Global Closed-loop Automated Insulin Delivery (AID) System Sales Market Share by Company (2019-2024)
Table 17. Global Closed-loop Automated Insulin Delivery (AID) System Revenue by Company (2019-2024) & ($ millions)
Table 18. Global Closed-loop Automated Insulin Delivery (AID) System Revenue Market Share by Company (2019-2024)
Table 19. Global Closed-loop Automated Insulin Delivery (AID) System Sale Price by Company (2019-2024) & (US$/Unit)
Table 20. Key Manufacturers Closed-loop Automated Insulin Delivery (AID) System Producing Area Distribution and Sales Area
Table 21. Players Closed-loop Automated Insulin Delivery (AID) System Products Offered
Table 22. Closed-loop Automated Insulin Delivery (AID) System Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Closed-loop Automated Insulin Delivery (AID) System Sales by Geographic Region (2019-2024) & (K Units)
Table 26. Global Closed-loop Automated Insulin Delivery (AID) System Sales Market Share Geographic Region (2019-2024)
Table 27. Global Closed-loop Automated Insulin Delivery (AID) System Revenue by Geographic Region (2019-2024) & ($ millions)
Table 28. Global Closed-loop Automated Insulin Delivery (AID) System Revenue Market Share by Geographic Region (2019-2024)
Table 29. Global Closed-loop Automated Insulin Delivery (AID) System Sales by Country/Region (2019-2024) & (K Units)
Table 30. Global Closed-loop Automated Insulin Delivery (AID) System Sales Market Share by Country/Region (2019-2024)
Table 31. Global Closed-loop Automated Insulin Delivery (AID) System Revenue by Country/Region (2019-2024) & ($ millions)
Table 32. Global Closed-loop Automated Insulin Delivery (AID) System Revenue Market Share by Country/Region (2019-2024)
Table 33. Americas Closed-loop Automated Insulin Delivery (AID) System Sales by Country (2019-2024) & (K Units)
Table 34. Americas Closed-loop Automated Insulin Delivery (AID) System Sales Market Share by Country (2019-2024)
Table 35. Americas Closed-loop Automated Insulin Delivery (AID) System Revenue by Country (2019-2024) & ($ millions)
Table 36. Americas Closed-loop Automated Insulin Delivery (AID) System Sales by Type (2019-2024) & (K Units)
Table 37. Americas Closed-loop Automated Insulin Delivery (AID) System Sales by Application (2019-2024) & (K Units)
Table 38. APAC Closed-loop Automated Insulin Delivery (AID) System Sales by Region (2019-2024) & (K Units)
Table 39. APAC Closed-loop Automated Insulin Delivery (AID) System Sales Market Share by Region (2019-2024)
Table 40. APAC Closed-loop Automated Insulin Delivery (AID) System Revenue by Region (2019-2024) & ($ millions)
Table 41. APAC Closed-loop Automated Insulin Delivery (AID) System Sales by Type (2019-2024) & (K Units)
Table 42. APAC Closed-loop Automated Insulin Delivery (AID) System Sales by Application (2019-2024) & (K Units)
Table 43. Europe Closed-loop Automated Insulin Delivery (AID) System Sales by Country (2019-2024) & (K Units)
Table 44. Europe Closed-loop Automated Insulin Delivery (AID) System Revenue by Country (2019-2024) & ($ millions)
Table 45. Europe Closed-loop Automated Insulin Delivery (AID) System Sales by Type (2019-2024) & (K Units)
Table 46. Europe Closed-loop Automated Insulin Delivery (AID) System Sales by Application (2019-2024) & (K Units)
Table 47. Middle East & Africa Closed-loop Automated Insulin Delivery (AID) System Sales by Country (2019-2024) & (K Units)
Table 48. Middle East & Africa Closed-loop Automated Insulin Delivery (AID) System Revenue Market Share by Country (2019-2024)
Table 49. Middle East & Africa Closed-loop Automated Insulin Delivery (AID) System Sales by Type (2019-2024) & (K Units)
Table 50. Middle East & Africa Closed-loop Automated Insulin Delivery (AID) System Sales by Application (2019-2024) & (K Units)
Table 51. Key Market Drivers & Growth Opportunities of Closed-loop Automated Insulin Delivery (AID) System
Table 52. Key Market Challenges & Risks of Closed-loop Automated Insulin Delivery (AID) System
Table 53. Key Industry Trends of Closed-loop Automated Insulin Delivery (AID) System
Table 54. Closed-loop Automated Insulin Delivery (AID) System Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Closed-loop Automated Insulin Delivery (AID) System Distributors List
Table 57. Closed-loop Automated Insulin Delivery (AID) System Customer List
Table 58. Global Closed-loop Automated Insulin Delivery (AID) System Sales Forecast by Region (2025-2030) & (K Units)
Table 59. Global Closed-loop Automated Insulin Delivery (AID) System Revenue Forecast by Region (2025-2030) & ($ millions)
Table 60. Americas Closed-loop Automated Insulin Delivery (AID) System Sales Forecast by Country (2025-2030) & (K Units)
Table 61. Americas Closed-loop Automated Insulin Delivery (AID) System Annual Revenue Forecast by Country (2025-2030) & ($ millions)
Table 62. APAC Closed-loop Automated Insulin Delivery (AID) System Sales Forecast by Region (2025-2030) & (K Units)
Table 63. APAC Closed-loop Automated Insulin Delivery (AID) System Annual Revenue Forecast by Region (2025-2030) & ($ millions)
Table 64. Europe Closed-loop Automated Insulin Delivery (AID) System Sales Forecast by Country (2025-2030) & (K Units)
Table 65. Europe Closed-loop Automated Insulin Delivery (AID) System Revenue Forecast by Country (2025-2030) & ($ millions)
Table 66. Middle East & Africa Closed-loop Automated Insulin Delivery (AID) System Sales Forecast by Country (2025-2030) & (K Units)
Table 67. Middle East & Africa Closed-loop Automated Insulin Delivery (AID) System Revenue Forecast by Country (2025-2030) & ($ millions)
Table 68. Global Closed-loop Automated Insulin Delivery (AID) System Sales Forecast by Type (2025-2030) & (K Units)
Table 69. Global Closed-loop Automated Insulin Delivery (AID) System Revenue Forecast by Type (2025-2030) & ($ millions)
Table 70. Global Closed-loop Automated Insulin Delivery (AID) System Sales Forecast by Application (2025-2030) & (K Units)
Table 71. Global Closed-loop Automated Insulin Delivery (AID) System Revenue Forecast by Application (2025-2030) & ($ millions)
Table 72. Medtronic Basic Information, Closed-loop Automated Insulin Delivery (AID) System Manufacturing Base, Sales Area and Its Competitors
Table 73. Medtronic Closed-loop Automated Insulin Delivery (AID) System Product Portfolios and Specifications
Table 74. Medtronic Closed-loop Automated Insulin Delivery (AID) System Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 75. Medtronic Main Business
Table 76. Medtronic Latest Developments
Table 77. Tandem Diabetes Care Basic Information, Closed-loop Automated Insulin Delivery (AID) System Manufacturing Base, Sales Area and Its Competitors
Table 78. Tandem Diabetes Care Closed-loop Automated Insulin Delivery (AID) System Product Portfolios and Specifications
Table 79. Tandem Diabetes Care Closed-loop Automated Insulin Delivery (AID) System Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 80. Tandem Diabetes Care Main Business
Table 81. Tandem Diabetes Care Latest Developments
Table 82. Admetsys Basic Information, Closed-loop Automated Insulin Delivery (AID) System Manufacturing Base, Sales Area and Its Competitors
Table 83. Admetsys Closed-loop Automated Insulin Delivery (AID) System Product Portfolios and Specifications
Table 84. Admetsys Closed-loop Automated Insulin Delivery (AID) System Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 85. Admetsys Main Business
Table 86. Admetsys Latest Developments
Table 87. Insulet Basic Information, Closed-loop Automated Insulin Delivery (AID) System Manufacturing Base, Sales Area and Its Competitors
Table 88. Insulet Closed-loop Automated Insulin Delivery (AID) System Product Portfolios and Specifications
Table 89. Insulet Closed-loop Automated Insulin Delivery (AID) System Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 90. Insulet Main Business
Table 91. Insulet Latest Developments
Table 92. Defymed Basic Information, Closed-loop Automated Insulin Delivery (AID) System Manufacturing Base, Sales Area and Its Competitors
Table 93. Defymed Closed-loop Automated Insulin Delivery (AID) System Product Portfolios and Specifications
Table 94. Defymed Closed-loop Automated Insulin Delivery (AID) System Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 95. Defymed Main Business
Table 96. Defymed Latest Developments
Table 97. Beta Bionics (iLet) Basic Information, Closed-loop Automated Insulin Delivery (AID) System Manufacturing Base, Sales Area and Its Competitors
Table 98. Beta Bionics (iLet) Closed-loop Automated Insulin Delivery (AID) System Product Portfolios and Specifications
Table 99. Beta Bionics (iLet) Closed-loop Automated Insulin Delivery (AID) System Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 100. Beta Bionics (iLet) Main Business
Table 101. Beta Bionics (iLet) Latest Developments
Table 102. Bigfoot Biomedical Basic Information, Closed-loop Automated Insulin Delivery (AID) System Manufacturing Base, Sales Area and Its Competitors
Table 103. Bigfoot Biomedical Closed-loop Automated Insulin Delivery (AID) System Product Portfolios and Specifications
Table 104. Bigfoot Biomedical Closed-loop Automated Insulin Delivery (AID) System Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 105. Bigfoot Biomedical Main Business
Table 106. Bigfoot Biomedical Latest Developments
Table 107. Dexcom Basic Information, Closed-loop Automated Insulin Delivery (AID) System Manufacturing Base, Sales Area and Its Competitors
Table 108. Dexcom Closed-loop Automated Insulin Delivery (AID) System Product Portfolios and Specifications
Table 109. Dexcom Closed-loop Automated Insulin Delivery (AID) System Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 110. Dexcom Main Business
Table 111. Dexcom Latest Developments
Table 112. MicroTech Medical (Hangzhou) Co., Ltd. Basic Information, Closed-loop Automated Insulin Delivery (AID) System Manufacturing Base, Sales Area and Its Competitors
Table 113. MicroTech Medical (Hangzhou) Co., Ltd. Closed-loop Automated Insulin Delivery (AID) System Product Portfolios and Specifications
Table 114. MicroTech Medical (Hangzhou) Co., Ltd. Closed-loop Automated Insulin Delivery (AID) System Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 115. MicroTech Medical (Hangzhou) Co., Ltd. Main Business
Table 116. MicroTech Medical (Hangzhou) Co., Ltd. Latest Developments
Table 117. Medtrum Basic Information, Closed-loop Automated Insulin Delivery (AID) System Manufacturing Base, Sales Area and Its Competitors
Table 118. Medtrum Closed-loop Automated Insulin Delivery (AID) System Product Portfolios and Specifications
Table 119. Medtrum Closed-loop Automated Insulin Delivery (AID) System Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 120. Medtrum Main Business
Table 121. Medtrum Latest Developments
LIST OF FIGURES
Figure 1. Picture of Closed-loop Automated Insulin Delivery (AID) System
Figure 2. Closed-loop Automated Insulin Delivery (AID) System Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Closed-loop Automated Insulin Delivery (AID) System Sales Growth Rate 2019-2030 (K Units)
Figure 7. Global Closed-loop Automated Insulin Delivery (AID) System Revenue Growth Rate 2019-2030 ($ millions)
Figure 8. Closed-loop Automated Insulin Delivery (AID) System Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 9. Closed-loop Automated Insulin Delivery (AID) System Sales Market Share by Country/Region (2023)
Figure 10. Closed-loop Automated Insulin Delivery (AID) System Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 11. Product Picture of Hybrid Closed Loop Systems
Figure 12. Product Picture of DIY Closed Loop Systems
Figure 13. Global Closed-loop Automated Insulin Delivery (AID) System Sales Market Share by Type in 2023
Figure 14. Global Closed-loop Automated Insulin Delivery (AID) System Revenue Market Share by Type (2019-2024)
Figure 15. Closed-loop Automated Insulin Delivery (AID) System Consumed in Children with Type 1 Diabetes
Figure 16. Global Closed-loop Automated Insulin Delivery (AID) System Market: Children with Type 1 Diabetes (2019-2024) & (K Units)
Figure 17. Closed-loop Automated Insulin Delivery (AID) System Consumed in Adults with Type 1 Diabetes
Figure 18. Global Closed-loop Automated Insulin Delivery (AID) System Market: Adults with Type 1 Diabetes (2019-2024) & (K Units)
Figure 19. Global Closed-loop Automated Insulin Delivery (AID) System Sale Market Share by Application (2023)
Figure 20. Global Closed-loop Automated Insulin Delivery (AID) System Revenue Market Share by Application in 2023
Figure 21. Closed-loop Automated Insulin Delivery (AID) System Sales by Company in 2023 (K Units)
Figure 22. Global Closed-loop Automated Insulin Delivery (AID) System Sales Market Share by Company in 2023
Figure 23. Closed-loop Automated Insulin Delivery (AID) System Revenue by Company in 2023 ($ millions)
Figure 24. Global Closed-loop Automated Insulin Delivery (AID) System Revenue Market Share by Company in 2023
Figure 25. Global Closed-loop Automated Insulin Delivery (AID) System Sales Market Share by Geographic Region (2019-2024)
Figure 26. Global Closed-loop Automated Insulin Delivery (AID) System Revenue Market Share by Geographic Region in 2023
Figure 27. Americas Closed-loop Automated Insulin Delivery (AID) System Sales 2019-2024 (K Units)
Figure 28. Americas Closed-loop Automated Insulin Delivery (AID) System Revenue 2019-2024 ($ millions)
Figure 29. APAC Closed-loop Automated Insulin Delivery (AID) System Sales 2019-2024 (K Units)
Figure 30. APAC Closed-loop Automated Insulin Delivery (AID) System Revenue 2019-2024 ($ millions)
Figure 31. Europe Closed-loop Automated Insulin Delivery (AID) System Sales 2019-2024 (K Units)
Figure 32. Europe Closed-loop Automated Insulin Delivery (AID) System Revenue 2019-2024 ($ millions)
Figure 33. Middle East & Africa Closed-loop Automated Insulin Delivery (AID) System Sales 2019-2024 (K Units)
Figure 34. Middle East & Africa Closed-loop Automated Insulin Delivery (AID) System Revenue 2019-2024 ($ millions)
Figure 35. Americas Closed-loop Automated Insulin Delivery (AID) System Sales Market Share by Country in 2023
Figure 36. Americas Closed-loop Automated Insulin Delivery (AID) System Revenue Market Share by Country (2019-2024)
Figure 37. Americas Closed-loop Automated Insulin Delivery (AID) System Sales Market Share by Type (2019-2024)
Figure 38. Americas Closed-loop Automated Insulin Delivery (AID) System Sales Market Share by Application (2019-2024)
Figure 39. United States Closed-loop Automated Insulin Delivery (AID) System Revenue Growth 2019-2024 ($ millions)
Figure 40. Canada Closed-loop Automated Insulin Delivery (AID) System Revenue Growth 2019-2024 ($ millions)
Figure 41. Mexico Closed-loop Automated Insulin Delivery (AID) System Revenue Growth 2019-2024 ($ millions)
Figure 42. Brazil Closed-loop Automated Insulin Delivery (AID) System Revenue Growth 2019-2024 ($ millions)
Figure 43. APAC Closed-loop Automated Insulin Delivery (AID) System Sales Market Share by Region in 2023
Figure 44. APAC Closed-loop Automated Insulin Delivery (AID) System Revenue Market Share by Region (2019-2024)
Figure 45. APAC Closed-loop Automated Insulin Delivery (AID) System Sales Market Share by Type (2019-2024)
Figure 46. APAC Closed-loop Automated Insulin Delivery (AID) System Sales Market Share by Application (2019-2024)
Figure 47. China Closed-loop Automated Insulin Delivery (AID) System Revenue Growth 2019-2024 ($ millions)
Figure 48. Japan Closed-loop Automated Insulin Delivery (AID) System Revenue Growth 2019-2024 ($ millions)
Figure 49. South Korea Closed-loop Automated Insulin Delivery (AID) System Revenue Growth 2019-2024 ($ millions)
Figure 50. Southeast Asia Closed-loop Automated Insulin Delivery (AID) System Revenue Growth 2019-2024 ($ millions)
Figure 51. India Closed-loop Automated Insulin Delivery (AID) System Revenue Growth 2019-2024 ($ millions)
Figure 52. Australia Closed-loop Automated Insulin Delivery (AID) System Revenue Growth 2019-2024 ($ millions)
Figure 53. China Taiwan Closed-loop Automated Insulin Delivery (AID) System Revenue Growth 2019-2024 ($ millions)
Figure 54. Europe Closed-loop Automated Insulin Delivery (AID) System Sales Market Share by Country in 2023
Figure 55. Europe Closed-loop Automated Insulin Delivery (AID) System Revenue Market Share by Country (2019-2024)
Figure 56. Europe Closed-loop Automated Insulin Delivery (AID) System Sales Market Share by Type (2019-2024)
Figure 57. Europe Closed-loop Automated Insulin Delivery (AID) System Sales Market Share by Application (2019-2024)
Figure 58. Germany Closed-loop Automated Insulin Delivery (AID) System Revenue Growth 2019-2024 ($ millions)
Figure 59. France Closed-loop Automated Insulin Delivery (AID) System Revenue Growth 2019-2024 ($ millions)
Figure 60. UK Closed-loop Automated Insulin Delivery (AID) System Revenue Growth 2019-2024 ($ millions)
Figure 61. Italy Closed-loop Automated Insulin Delivery (AID) System Revenue Growth 2019-2024 ($ millions)
Figure 62. Russia Closed-loop Automated Insulin Delivery (AID) System Revenue Growth 2019-2024 ($ millions)
Figure 63. Middle East & Africa Closed-loop Automated Insulin Delivery (AID) System Sales Market Share by Country (2019-2024)
Figure 64. Middle East & Africa Closed-loop Automated Insulin Delivery (AID) System Sales Market Share by Type (2019-2024)
Figure 65. Middle East & Africa Closed-loop Automated Insulin Delivery (AID) System Sales Market Share by Application (2019-2024)
Figure 66. Egypt Closed-loop Automated Insulin Delivery (AID) System Revenue Growth 2019-2024 ($ millions)
Figure 67. South Africa Closed-loop Automated Insulin Delivery (AID) System Revenue Growth 2019-2024 ($ millions)
Figure 68. Israel Closed-loop Automated Insulin Delivery (AID) System Revenue Growth 2019-2024 ($ millions)
Figure 69. Turkey Closed-loop Automated Insulin Delivery (AID) System Revenue Growth 2019-2024 ($ millions)
Figure 70. GCC Countries Closed-loop Automated Insulin Delivery (AID) System Revenue Growth 2019-2024 ($ millions)
Figure 71. Manufacturing Cost Structure Analysis of Closed-loop Automated Insulin Delivery (AID) System in 2023
Figure 72. Manufacturing Process Analysis of Closed-loop Automated Insulin Delivery (AID) System
Figure 73. Industry Chain Structure of Closed-loop Automated Insulin Delivery (AID) System
Figure 74. Channels of Distribution
Figure 75. Global Closed-loop Automated Insulin Delivery (AID) System Sales Market Forecast by Region (2025-2030)
Figure 76. Global Closed-loop Automated Insulin Delivery (AID) System Revenue Market Share Forecast by Region (2025-2030)
Figure 77. Global Closed-loop Automated Insulin Delivery (AID) System Sales Market Share Forecast by Type (2025-2030)
Figure 78. Global Closed-loop Automated Insulin Delivery (AID) System Revenue Market Share Forecast by Type (2025-2030)
Figure 79. Global Closed-loop Automated Insulin Delivery (AID) System Sales Market Share Forecast by Application (2025-2030)
Figure 80. Global Closed-loop Automated Insulin Delivery (AID) System Revenue Market Share Forecast by Application (2025-2030)
Figure 1. Picture of Closed-loop Automated Insulin Delivery (AID) System
Figure 2. Closed-loop Automated Insulin Delivery (AID) System Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Closed-loop Automated Insulin Delivery (AID) System Sales Growth Rate 2019-2030 (K Units)
Figure 7. Global Closed-loop Automated Insulin Delivery (AID) System Revenue Growth Rate 2019-2030 ($ millions)
Figure 8. Closed-loop Automated Insulin Delivery (AID) System Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 9. Closed-loop Automated Insulin Delivery (AID) System Sales Market Share by Country/Region (2023)
Figure 10. Closed-loop Automated Insulin Delivery (AID) System Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 11. Product Picture of Hybrid Closed Loop Systems
Figure 12. Product Picture of DIY Closed Loop Systems
Figure 13. Global Closed-loop Automated Insulin Delivery (AID) System Sales Market Share by Type in 2023
Figure 14. Global Closed-loop Automated Insulin Delivery (AID) System Revenue Market Share by Type (2019-2024)
Figure 15. Closed-loop Automated Insulin Delivery (AID) System Consumed in Children with Type 1 Diabetes
Figure 16. Global Closed-loop Automated Insulin Delivery (AID) System Market: Children with Type 1 Diabetes (2019-2024) & (K Units)
Figure 17. Closed-loop Automated Insulin Delivery (AID) System Consumed in Adults with Type 1 Diabetes
Figure 18. Global Closed-loop Automated Insulin Delivery (AID) System Market: Adults with Type 1 Diabetes (2019-2024) & (K Units)
Figure 19. Global Closed-loop Automated Insulin Delivery (AID) System Sale Market Share by Application (2023)
Figure 20. Global Closed-loop Automated Insulin Delivery (AID) System Revenue Market Share by Application in 2023
Figure 21. Closed-loop Automated Insulin Delivery (AID) System Sales by Company in 2023 (K Units)
Figure 22. Global Closed-loop Automated Insulin Delivery (AID) System Sales Market Share by Company in 2023
Figure 23. Closed-loop Automated Insulin Delivery (AID) System Revenue by Company in 2023 ($ millions)
Figure 24. Global Closed-loop Automated Insulin Delivery (AID) System Revenue Market Share by Company in 2023
Figure 25. Global Closed-loop Automated Insulin Delivery (AID) System Sales Market Share by Geographic Region (2019-2024)
Figure 26. Global Closed-loop Automated Insulin Delivery (AID) System Revenue Market Share by Geographic Region in 2023
Figure 27. Americas Closed-loop Automated Insulin Delivery (AID) System Sales 2019-2024 (K Units)
Figure 28. Americas Closed-loop Automated Insulin Delivery (AID) System Revenue 2019-2024 ($ millions)
Figure 29. APAC Closed-loop Automated Insulin Delivery (AID) System Sales 2019-2024 (K Units)
Figure 30. APAC Closed-loop Automated Insulin Delivery (AID) System Revenue 2019-2024 ($ millions)
Figure 31. Europe Closed-loop Automated Insulin Delivery (AID) System Sales 2019-2024 (K Units)
Figure 32. Europe Closed-loop Automated Insulin Delivery (AID) System Revenue 2019-2024 ($ millions)
Figure 33. Middle East & Africa Closed-loop Automated Insulin Delivery (AID) System Sales 2019-2024 (K Units)
Figure 34. Middle East & Africa Closed-loop Automated Insulin Delivery (AID) System Revenue 2019-2024 ($ millions)
Figure 35. Americas Closed-loop Automated Insulin Delivery (AID) System Sales Market Share by Country in 2023
Figure 36. Americas Closed-loop Automated Insulin Delivery (AID) System Revenue Market Share by Country (2019-2024)
Figure 37. Americas Closed-loop Automated Insulin Delivery (AID) System Sales Market Share by Type (2019-2024)
Figure 38. Americas Closed-loop Automated Insulin Delivery (AID) System Sales Market Share by Application (2019-2024)
Figure 39. United States Closed-loop Automated Insulin Delivery (AID) System Revenue Growth 2019-2024 ($ millions)
Figure 40. Canada Closed-loop Automated Insulin Delivery (AID) System Revenue Growth 2019-2024 ($ millions)
Figure 41. Mexico Closed-loop Automated Insulin Delivery (AID) System Revenue Growth 2019-2024 ($ millions)
Figure 42. Brazil Closed-loop Automated Insulin Delivery (AID) System Revenue Growth 2019-2024 ($ millions)
Figure 43. APAC Closed-loop Automated Insulin Delivery (AID) System Sales Market Share by Region in 2023
Figure 44. APAC Closed-loop Automated Insulin Delivery (AID) System Revenue Market Share by Region (2019-2024)
Figure 45. APAC Closed-loop Automated Insulin Delivery (AID) System Sales Market Share by Type (2019-2024)
Figure 46. APAC Closed-loop Automated Insulin Delivery (AID) System Sales Market Share by Application (2019-2024)
Figure 47. China Closed-loop Automated Insulin Delivery (AID) System Revenue Growth 2019-2024 ($ millions)
Figure 48. Japan Closed-loop Automated Insulin Delivery (AID) System Revenue Growth 2019-2024 ($ millions)
Figure 49. South Korea Closed-loop Automated Insulin Delivery (AID) System Revenue Growth 2019-2024 ($ millions)
Figure 50. Southeast Asia Closed-loop Automated Insulin Delivery (AID) System Revenue Growth 2019-2024 ($ millions)
Figure 51. India Closed-loop Automated Insulin Delivery (AID) System Revenue Growth 2019-2024 ($ millions)
Figure 52. Australia Closed-loop Automated Insulin Delivery (AID) System Revenue Growth 2019-2024 ($ millions)
Figure 53. China Taiwan Closed-loop Automated Insulin Delivery (AID) System Revenue Growth 2019-2024 ($ millions)
Figure 54. Europe Closed-loop Automated Insulin Delivery (AID) System Sales Market Share by Country in 2023
Figure 55. Europe Closed-loop Automated Insulin Delivery (AID) System Revenue Market Share by Country (2019-2024)
Figure 56. Europe Closed-loop Automated Insulin Delivery (AID) System Sales Market Share by Type (2019-2024)
Figure 57. Europe Closed-loop Automated Insulin Delivery (AID) System Sales Market Share by Application (2019-2024)
Figure 58. Germany Closed-loop Automated Insulin Delivery (AID) System Revenue Growth 2019-2024 ($ millions)
Figure 59. France Closed-loop Automated Insulin Delivery (AID) System Revenue Growth 2019-2024 ($ millions)
Figure 60. UK Closed-loop Automated Insulin Delivery (AID) System Revenue Growth 2019-2024 ($ millions)
Figure 61. Italy Closed-loop Automated Insulin Delivery (AID) System Revenue Growth 2019-2024 ($ millions)
Figure 62. Russia Closed-loop Automated Insulin Delivery (AID) System Revenue Growth 2019-2024 ($ millions)
Figure 63. Middle East & Africa Closed-loop Automated Insulin Delivery (AID) System Sales Market Share by Country (2019-2024)
Figure 64. Middle East & Africa Closed-loop Automated Insulin Delivery (AID) System Sales Market Share by Type (2019-2024)
Figure 65. Middle East & Africa Closed-loop Automated Insulin Delivery (AID) System Sales Market Share by Application (2019-2024)
Figure 66. Egypt Closed-loop Automated Insulin Delivery (AID) System Revenue Growth 2019-2024 ($ millions)
Figure 67. South Africa Closed-loop Automated Insulin Delivery (AID) System Revenue Growth 2019-2024 ($ millions)
Figure 68. Israel Closed-loop Automated Insulin Delivery (AID) System Revenue Growth 2019-2024 ($ millions)
Figure 69. Turkey Closed-loop Automated Insulin Delivery (AID) System Revenue Growth 2019-2024 ($ millions)
Figure 70. GCC Countries Closed-loop Automated Insulin Delivery (AID) System Revenue Growth 2019-2024 ($ millions)
Figure 71. Manufacturing Cost Structure Analysis of Closed-loop Automated Insulin Delivery (AID) System in 2023
Figure 72. Manufacturing Process Analysis of Closed-loop Automated Insulin Delivery (AID) System
Figure 73. Industry Chain Structure of Closed-loop Automated Insulin Delivery (AID) System
Figure 74. Channels of Distribution
Figure 75. Global Closed-loop Automated Insulin Delivery (AID) System Sales Market Forecast by Region (2025-2030)
Figure 76. Global Closed-loop Automated Insulin Delivery (AID) System Revenue Market Share Forecast by Region (2025-2030)
Figure 77. Global Closed-loop Automated Insulin Delivery (AID) System Sales Market Share Forecast by Type (2025-2030)
Figure 78. Global Closed-loop Automated Insulin Delivery (AID) System Revenue Market Share Forecast by Type (2025-2030)
Figure 79. Global Closed-loop Automated Insulin Delivery (AID) System Sales Market Share Forecast by Application (2025-2030)
Figure 80. Global Closed-loop Automated Insulin Delivery (AID) System Revenue Market Share Forecast by Application (2025-2030)
